Hillen HF - Search Results

1

The unknown biology of the unknown primary tumour: a literature review.

van de Wouw AJ, Jansen RL, Speel EJ, Hillen HF. van de Wouw AJ, et al. Among authors: hillen hf. Ann Oncol. 2003 Feb;14(2):191-6. doi: 10.1093/annonc/mdg068. Ann Oncol. 2003. PMID: 12562643 Free article. Review.

2

Clinical and immunohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT.

van de Wouw AJ, Jansen RL, Griffioen AW, Hillen HF. van de Wouw AJ, et al. Among authors: hillen hf. Anticancer Res. 2004 Jan-Feb;24(1):297-301. Anticancer Res. 2004. PMID: 15015611 Free article.

3

Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992.

van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW, Hillen HF. van de Wouw AJ, et al. Among authors: hillen hf. Eur J Cancer. 2002 Feb;38(3):409-13. doi: 10.1016/s0959-8049(01)00378-1. Eur J Cancer. 2002. PMID: 11818207

4

Molecular evidence for a clonal relationship between multiple lesions in patients with unknown primary adenocarcinoma.

Speel EJ, van de Wouw AJ, Claessen SM, Haesevoets A, Hopman AH, van der Wurff AA, Osieka R, Buettner R, Hillen HF, Ramaekers FC. Speel EJ, et al. Among authors: hillen hf. Int J Cancer. 2008 Sep 15;123(6):1292-300. doi: 10.1002/ijc.23616. Int J Cancer. 2008. PMID: 18561313

5

Prognostic and predictive factors in breast cancer.

Jansen RL, Hillen HF, Schouten HC. Jansen RL, et al. Among authors: hillen hf. Neth J Med. 1997 Aug;51(2):65-77. doi: 10.1016/s0300-2977(97)00021-1. Neth J Med. 1997. PMID: 9286143 Review. No abstract available.

6

pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer.

Jansen RL, Hupperets PS, Arends JW, Joosten-Achjanie SR, Volovics A, Hillen HF, Schouten HC. Jansen RL, et al. Among authors: hillen hf. Anticancer Res. 1998 Jan-Feb;18(1B):577-82. Anticancer Res. 1998. PMID: 9568180

7

Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer.

Jansen RL, Joosten-Achjanie SR, Volovics A, Arends JW, Hupperets PS, Hillen HF, Schouten HC. Jansen RL, et al. Among authors: hillen hf. Anticancer Res. 1998 Nov-Dec;18(6A):4455-62. Anticancer Res. 1998. PMID: 9891509

8

MIB-1 labelling index is an independent prognostic marker in primary breast cancer.

Jansen RL, Hupperets PS, Arends JW, Joosten-Achjanie SR, Volovics A, Schouten HC, Hillen HF. Jansen RL, et al. Among authors: hillen hf. Br J Cancer. 1998 Aug;78(4):460-5. doi: 10.1038/bjc.1998.515. Br J Cancer. 1998. PMID: 9716027 Free PMC article.

9

CD44v6 is not a prognostic factor in primary breast cancer.

Jansen RH, Joosten-Achjanie SR, Arends JW, Volovics A, Hupperets PS, Schouten HC, Hillen HF. Jansen RH, et al. Among authors: hillen hf. Ann Oncol. 1998 Jan;9(1):109-11. doi: 10.1023/a:1008220917687. Ann Oncol. 1998. PMID: 9541692 Free article. Clinical Trial.

10

Unknown primary tumours.

Hillen HF. Hillen HF. Postgrad Med J. 2000 Nov;76(901):690-3. doi: 10.1136/pmj.76.901.690. Postgrad Med J. 2000. PMID: 11060142 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters